1. Home
  2. JSPR vs BARK Comparison

JSPR vs BARK Comparison

Compare JSPR & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

N/A

Current Price

$10.00

Market Cap

26.3M

Sector

Health Care

ML Signal

N/A

Logo BARK Inc.

BARK

BARK Inc.

SELL

Current Price

$8.75

Market Cap

73.7M

ML Signal

SELL

Company Overview

Basic Information
Metric
JSPR
BARK
Founded
2018
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
73.7M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
JSPR
BARK
Price
$10.00
$8.75
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
★ $249.83
$17.00
AVG Volume (30 Days)
★ 257.9K
28.5K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 19.22
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $394,843,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.03
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.32
$0.50
52 Week High
$17.03
$11.32

Technical Indicators

Market Signals
Indicator
JSPR
BARK
Relative Strength Index (RSI) 58.04 52.22
Support Level $0.64 $8.14
Resistance Level $17.03 $9.97
Average True Range (ATR) 1.67 0.59
MACD -0.06 0.01
Stochastic Oscillator 54.49 49.08

Price Performance

Historical Comparison
JSPR
BARK

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

About BARK BARK Inc.

BARK Inc believe that dogs and humans are good together and it aspire to be the world's favorite dog brand. It is a team of dog-obsessed people committed to delivering personalization at scale by satisfying each dog's distinct personality, preferences, and needs with the products and services. It is an omnichannel brand that designs and develops proprietary products for dogs across two key brands: BarkBox and Super Chewer. All of its products are designed and developed in-house, and are BARK branded. Its segments are DTC, and Commerce. It generates majority of revenue from DTC. Direct to Consumer generates revenue from subscription products that feature monthly themes of premium quality BarkBox and Super Chewer toys and BARK-branded treats and chews.

Share on Social Networks: